Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11303039 | 0.81 | ALDH1A1 (0.36) | ALDH1A1MAPK1 | |
| SCHEMBL1263625 | 0.76 | — | — | |
| SCHEMBL3297798 | 0.74 | ALDH1A1 (0.41) | ALDH1A1MAPK1 | |
| SCHEMBL14777666 | 0.74 | TSHR (0.36) | ALDH1A1MAPK1 | |
| SCHEMBL3177179 | 0.73 | — | — | |
| SCHEMBL10709365 | 0.70 | ALDH1A1 (0.32) | ALDH1A1MAPK1 | |
| SCHEMBL28812268 | 0.70 | ALDH1A1 (0.32) | ALDH1A1MAPK1 | |
| SCHEMBL29225868 | 0.70 | MAPK1 (0.32) | MAPK1 | |
| SCHEMBL137282 | 0.69 | — | — | |
| SCHEMBL30608277 | 0.69 | MAPK1 (0.39) | ALDH1A1MAPK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 24 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20120258960-A1 | NOVEL MULTIFUNCTIONAL PEPTIDASE INHIBITORS, ESPECIALLY FOR MEDICAL USE | IMTM GMBH (DE) | 2012-10-11 | — | — | US | disclosed |
| US-20120028995-A1 | NOVEL COMPOUNDS FOR MEDICAL USE AS PEPTIDASE EFFECTORS | IMTM GMBH (DE) | 2012-02-02 | — | — | US | disclosed |
| WO-2011026781-A1 | NOVEL MULTIFUNCTIONAL PEPTIDASE INHIBITORS, ESPECIALLY FOR MEDICAL USE | IMTM GMBH (DE) | 2011-03-10 | — | — | WO | disclosed |
| EP-2292589-A1 | Novel multifunctional peptidase inhibitors, especially for medical use | IMTM GmbH (DE) | 2011-03-09 | — | — | EP | disclosed |
| US-7605111-B2 | Herbicides | SYNGENTA CROP PROTECTION, INC. (US) | 2009-10-20 | — | — | US | disclosed |
| CN-100509798-C | Trisubstituted aryl and heteroaryl derivatives as modulators of metabolism and the prevention and treatment of disorders related thereto | ARENA PHARM INC (US) | 2009-07-08 | — | — | CN | disclosed |
| EP-1675832-B1 | HETEROCYCLYL COMPOUNDS | GLAXO GROUP LTD (GB) | 2008-02-20 | — | — | EP | disclosed |
| CN-1307139-C | Method of producing p-hydroxyphenylalkanols | SUMITOMO CHEMICAL CO (JP) | 2007-03-28 | — | — | CN | disclosed |
| US-20070060596-A1 | Heterocyclyl compounds | GLAXO GROUP LIMITED (GB) | 2007-03-15 | — | — | US | disclosed |
| US-20070049773-A1 | Process for functionalising a phenolic compound carrying an electron-donating group | MIOSKOWSKI CHARLES | 2007-03-01 | — | — | US | disclosed |
| WO-2005037794-A1 | CYCLOHEXENE COMPOUNDS | GLAXO GROUP LIMITED (GB) | 2005-04-28 | — | — | WO | disclosed |
| CN-1448379-A | Method of producing p-hydroxyphenylalkanols | SUMITOMO CHEMICAL CO (JP) | 2003-10-15 | — | — | CN | disclosed |
| CN-1090935-C | Pharmaceutical composition for piperidinoalkanol compounds | AVENTIS PHARMA INC (US) | 2002-09-18 | — | — | CN | disclosed |
| CN-1176599-A | Pharmaceutical composition for piperidinoalkanol compounds | HOECHST MARION ROUSSEL INC (US) | 1998-03-18 | — | — | CN | disclosed |
| CN-1036112-C | Diamino-vinyl compounds | TAKEDA PHARMACEUTICAL IND K K (JP) | 1997-10-15 | — | — | CN | disclosed |
| CN-1034501-C | (Bemzhydryloxyethylpiperidyl) aliphatic acid derivatives and their use in the treatment of allergies and asthma | SANKYO CO (JP) | 1997-04-09 | — | — | CN | disclosed |
| US-5204458-A | Reacting an allenyl beta-lactam with a nucleophilic agent | OTSUKA KAGAKU KABUSHIKI KAISHA (JP) | 1993-04-20 | — | — | US | disclosed |
| CN-1046896-A | DIAMINO-VINYL COMPOUNDS | TAKEDA CHEMICAL INDUSTRIES LTD (JP) | 1990-11-14 | — | — | CN | disclosed |
| US-4680385-A | Metal dye complexes containing an azo or azomethine dye and a colorless ligand with the C═N--N═C group | CIBA-GEIGY CORPORATION (US) | 1987-07-14 | — | — | US | disclosed |
| US-4239897-A | Thiophene compounds and their manufacture | BASF AKTIENGESELLSCHAFT (DE) | 1980-12-16 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070049773-A1 | Process for functionalising a phenolic compound carrying an electron-donating group | COMT, ETFA, LPO | ALDH1A1 620/4885MAPK1 1959/4885 |
| US-20120028995-A1 | NOVEL COMPOUNDS FOR MEDICAL USE AS PEPTIDASE EFFECTORS | SERPINB1, CMA1, CPA3 | ALDH1A1 961/4885MAPK1 1292/4885 |
| US-20120258960-A1 | NOVEL MULTIFUNCTIONAL PEPTIDASE INHIBITORS, ESPECIALLY FOR MEDICAL USE | PEPD, CTSC, SERPINB1 | ALDH1A1 808/4885MAPK1 1940/4885 |
| US-20070060596-A1 | Heterocyclyl compounds | F9, F12, CYP2C9 | ALDH1A1 3505/4885MAPK1 3877/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.